Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Timothy W Schacker

Showing results (61-70 of 88) with videos related to

Pageof 9
Sort By:
Journal of Virology|July 20, 2022
Detecting Sources of Immune Activation and Viral Rebound in HIV InfectionStephen W Wietgrefe, Lijie Duan, Jodi Anderson, et al.
Science (New York, N.Y.)|June 6, 2009
A step ahead on the HIV collaboratoryRobert L Murphy, Brigitte Autran, Christine Katlama, et al.
Microbiology Spectrum|September 30, 2024
SARS-CoV-2 infection is associated with intestinal permeability, systemic inflammation, and microbial dysbiosis in hospitalized patientsChristopher M Basting, Robert Langat, Courtney A Broedlow, et al.
The Journal of Infectious Diseases|September 24, 2014
Antifibrotic therapy in simian immunodeficiency virus infection preserves CD4+ T-cell populations and improves immune reconstitution with antiretroviral therapyJacob D Estes, Cavan Reilly, Charles M Trubey, et al.
JCI Insight|June 22, 2022
Boosting corrects a memory B cell defect in SARS-CoV-2 mRNA-vaccinated patients with inflammatory bowel diseaseKathryn A Pape, Thamotharampillai Dileepan, William E Matchett, et al.
JCI Insight|July 23, 2016
Impact of early cART in the gut during acute HIV infectionClaire Deleage, Alexandra Schuetz, W Gregory Alvord, et al.
Nature Medicine|February 1, 2022
Safety and virologic impact of the IL-15 superagonist N-803 in people living with HIV: a phase 1 trialJeffrey S Miller, Zachary B Davis, Erika Helgeson, et al.
Nature Medicine|November 23, 2006
Microbial translocation is a cause of systemic immune activation in chronic HIV infectionJason M Brenchley, David A Price, Timothy W Schacker, et al.
Blood|February 21, 2013
Impaired T-cell responses to sphingosine-1-phosphate in HIV-1 infected lymph nodesJoseph C Mudd, Patrick Murphy, Maura Manion, et al.
Eclinicalmedicine|July 1, 2021
A multi-center phase II randomized clinical trial of losartan on symptomatic outpatients with COVID-19Michael A Puskarich, Nathan W Cummins, Nicholas E Ingraham, et al.
Pageof 9

Showing results (61-70 of 88) with videos related to

Sort By:
Pageof 9
Journal of Virology|July 20, 2022
Detecting Sources of Immune Activation and Viral Rebound in HIV InfectionStephen W Wietgrefe, Lijie Duan, Jodi Anderson, et al.
Science (New York, N.Y.)|June 6, 2009
A step ahead on the HIV collaboratoryRobert L Murphy, Brigitte Autran, Christine Katlama, et al.
Microbiology Spectrum|September 30, 2024
SARS-CoV-2 infection is associated with intestinal permeability, systemic inflammation, and microbial dysbiosis in hospitalized patientsChristopher M Basting, Robert Langat, Courtney A Broedlow, et al.
The Journal of Infectious Diseases|September 24, 2014
Antifibrotic therapy in simian immunodeficiency virus infection preserves CD4+ T-cell populations and improves immune reconstitution with antiretroviral therapyJacob D Estes, Cavan Reilly, Charles M Trubey, et al.
JCI Insight|June 22, 2022
Boosting corrects a memory B cell defect in SARS-CoV-2 mRNA-vaccinated patients with inflammatory bowel diseaseKathryn A Pape, Thamotharampillai Dileepan, William E Matchett, et al.
JCI Insight|July 23, 2016
Impact of early cART in the gut during acute HIV infectionClaire Deleage, Alexandra Schuetz, W Gregory Alvord, et al.
Nature Medicine|February 1, 2022
Safety and virologic impact of the IL-15 superagonist N-803 in people living with HIV: a phase 1 trialJeffrey S Miller, Zachary B Davis, Erika Helgeson, et al.
Nature Medicine|November 23, 2006
Microbial translocation is a cause of systemic immune activation in chronic HIV infectionJason M Brenchley, David A Price, Timothy W Schacker, et al.
Blood|February 21, 2013
Impaired T-cell responses to sphingosine-1-phosphate in HIV-1 infected lymph nodesJoseph C Mudd, Patrick Murphy, Maura Manion, et al.
Eclinicalmedicine|July 1, 2021
A multi-center phase II randomized clinical trial of losartan on symptomatic outpatients with COVID-19Michael A Puskarich, Nathan W Cummins, Nicholas E Ingraham, et al.
Pageof 9